Multi-Institution Analysis of Tarlatamab for the Treatment of EGFR-Mutant Transformed Small Cell Lung Cancer

Authors

Alissa J Cooper
Benjamin Herzberg
Mitchell Parma
Kaiwen Wang
Laura Alder
Urs M Weber
Tejas Patil
Utsav Joshi
Sonam Puri
Anjali Saqi
Phoebe Clark
Carl M Gay
Tina Cascone
Eric K Singhi
George Blumenschein
Ferdinandos Skoulidis
Janet Tu
Thomas E Stinchcombe
Charles M Rudin
Catherine A Shu
Lauren A Byers
Helena Yu
Bingnan Zhang

Language

English

Publication Date

10-1-2025

Journal

JCO Precision Oncology

DOI

10.1200/PO-25-00538

PMID

41166675

PMCID

PMC12670137

PubMedCentral® Posted Date

12-3-2025

PubMedCentral® Full Text Version

Author MSS

Published Open-Access

yes

Recommended Citation

Cooper, Alissa J; Herzberg, Benjamin; Parma, Mitchell; et al., "Multi-Institution Analysis of Tarlatamab for the Treatment of EGFR-Mutant Transformed Small Cell Lung Cancer" (2025). Faculty, Staff and Student Publications. 5406.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5406